BRAF and neoplasm: Although a causal relationship between BRAF mutation and PGE2 production is further to be determined, the findings of this study may suggest that driver mutation can render tumour cells malignant phenotypes through modulation of the microenvironment to a pro-tumoural niche rather than direct growth advantages.